Pacibekitug (IL-6 ligand mAb) in patients with CKD and high CV risk

TRANQUILITY

Response-tailored duration of antibiotic treatment for infectious endocarditis

POET-II

Implementation of SGLT2 inhibitors in patients with HF through a digital strategy

EMAIL-HF

Milvexian after recent ACS

LIBREXIA ACS

Plozasiran in severe hypertriglyceridaemia

SHASTA-3/4

Team-based collaborative care model in HF

TIME-HF

Efficacy and safety of eplontersen in patients with transthyretin amyloid cardiomyopathy (ATTR-CM)

CARDIO-TRansform

Anticoagulation for Atrial Fibrillation with Intermediate Stroke Risk

SINGLE-AF

Statins for Reducing Events in the Elderly

STAREE

Aficamten for Symptomatic non-obstructive HypertrophicCardiomyopathy